These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8544852)
1. A synthetic peptide-based polyoxime vaccine construct of high purity and activity. Rose K; Zeng W; Brown LE; Jackson DC Mol Immunol; 1995 Oct; 32(14-15):1031-7. PubMed ID: 8544852 [TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. Nardin EH; Calvo-Calle JM; Oliveira GA; Clavijo P; Nussenzweig R; Simon R; Zeng W; Rose K Vaccine; 1998 Apr; 16(6):590-600. PubMed ID: 9569470 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of a new template with a built-in adjuvant and its use in constructing peptide vaccine candidates through polyoxime chemistry. Zeng W; Jackson DC; Rose K J Pept Sci; 1996; 2(1):66-72. PubMed ID: 9225247 [TBL] [Abstract][Full Text] [Related]
4. Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens. Zeng W; Jackson DC; Murray J; Rose K; Brown LE Vaccine; 2000 Jan; 18(11-12):1031-9. PubMed ID: 10590323 [TBL] [Abstract][Full Text] [Related]
5. Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory. Naruse H; Ogasawara K; Takami K; Kajino K; Gotohda T; Itoh Y; Miyazaki T; Good RA; Onoè K Vaccine; 1994 Jul; 12(9):776-82. PubMed ID: 7526571 [TBL] [Abstract][Full Text] [Related]
6. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types. Nardin EH; Calvo-Calle JM; Oliveira GA; Nussenzweig RS; Schneider M; Tiercy JM; Loutan L; Hochstrasser D; Rose K J Immunol; 2001 Jan; 166(1):481-9. PubMed ID: 11123327 [TBL] [Abstract][Full Text] [Related]
7. Determination of the agretopic residues of a peptide co-restricted to different class II isotypes, I-Au and I-Eu, and its application for preparation of a synthetic peptide vaccine against influenza virus A/Aichi/2/68. Takami K; Ogasawara K; Itoh Y; Kajino K; Naruse H; Onoé K Microbiol Immunol; 1994; 38(10):779-87. PubMed ID: 7532781 [TBL] [Abstract][Full Text] [Related]
8. Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses. Chen WA; Zhang J; Hall KM; Martin CB; Kisselev S; Dasen EJ; Vahanian NN; Link CJ; Martin BK PLoS One; 2017; 12(8):e0182683. PubMed ID: 28787006 [TBL] [Abstract][Full Text] [Related]
9. Branched polypeptides as antigens for influenza virus hemagglutinin and T-cell receptor subunits. Tóth GK; Váradi G; Nagy Z; Monostori E; Penke B; Hegedüs Z; Andó I; Fazekas G; Kurucz I; Mák M Pept Res; 1993; 6(5):272-80. PubMed ID: 8257803 [TBL] [Abstract][Full Text] [Related]
10. A novel M2e-multiple antigenic peptide providing heterologous protection in mice. Wen F; Ma JH; Yu H; Yang FR; Huang M; Zhou YJ; Li ZJ; Wang XH; Li GX; Jiang YF; Tong W; Tong GZ J Vet Sci; 2016 Mar; 17(1):71-8. PubMed ID: 27051342 [TBL] [Abstract][Full Text] [Related]
11. [Development of synthetic peptide vaccine against influenza--T cell epitope the hemagglutinin of A/Aichi/2/68(H3N2) influenza virus induced immune response in mice]. Naruse H Hokkaido Igaku Zasshi; 1994 Jul; 69(4):811-20. PubMed ID: 7525436 [TBL] [Abstract][Full Text] [Related]
12. Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin. Simeckova-Rosenberg J; Yun Z; Wyde PR; Atassi MZ Vaccine; 1995 Jul; 13(10):927-32. PubMed ID: 7483766 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle. Anggraeni MR; Connors NK; Wu Y; Chuan YP; Lua LH; Middelberg AP Vaccine; 2013 Sep; 31(40):4428-35. PubMed ID: 23845811 [TBL] [Abstract][Full Text] [Related]
14. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Levi R; Aboud-Pirak E; Leclerc C; Lowell GH; Arnon R Vaccine; 1995 Oct; 13(14):1353-9. PubMed ID: 8585293 [TBL] [Abstract][Full Text] [Related]
15. Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection. Levi R; Arnon R Vaccine; 1996 Jan; 14(1):85-92. PubMed ID: 8821654 [TBL] [Abstract][Full Text] [Related]
16. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity. Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499 [TBL] [Abstract][Full Text] [Related]
17. A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling. Thérien A; Bédard M; Carignan D; Rioux G; Gauthier-Landry L; Laliberté-Gagné MÈ; Bolduc M; Savard P; Leclerc D J Nanobiotechnology; 2017 Jul; 15(1):54. PubMed ID: 28720097 [TBL] [Abstract][Full Text] [Related]
18. Chemical Platforms for Peptide Vaccine Constructs. Ramesh S; Cherkupally P; Govender T; Kruger HG; Albericio F; de la Torre BG Adv Protein Chem Struct Biol; 2015; 99():99-130. PubMed ID: 26067818 [TBL] [Abstract][Full Text] [Related]
19. Self-assembly polymerization enhances the immunogenicity of influenza M2e peptide. Zou P; Li Y; Huang J; Wu F Microbes Infect; 2017 Dec; 19(12):648-654. PubMed ID: 28939356 [TBL] [Abstract][Full Text] [Related]
20. Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets. Rosendahl Huber SK; Camps MG; Jacobi RH; Mouthaan J; van Dijken H; van Beek J; Ossendorp F; de Jonge J PLoS One; 2015; 10(6):e0127969. PubMed ID: 26046664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]